• Lab-Verified Research Peptides
GLOW _ 70mg

GLOW

$90.00$100.00 Save 10%

In stock

Buy the GLOW peptide blend at Velora Research. GLOW is a research-grade three-peptide stack combining 50mg of the copper peptide GHK-Cu with 10mg of TB-500 and 10mg of BPC-157 in a single 70mg lyophilized vial. Supplied for in vitro and preclinical investigation of tissue-remodeling, copper-transport, and matrix-research pathways. Each batch is independently HPLC and mass-spec verified at 99% or higher purity, with a downloadable Certificate of Analysis tied to the lot number. Strictly for laboratory research use, not for human, veterinary, or cosmetic use.

  • Purity: ≥99%
  • Form: Lyophilized Powder
  • Free shipping on orders $200+. 2-day US delivery.

Specifications

Purity
≥99%
Form
Lyophilized Powder
Storage
Store at -20°C

About GLOW peptides (research blend)

GLOW peptides are a proprietary three-component research stack from Velora Research. Each 70mg lyophilized vial contains the copper-bound tripeptide GHK-Cu (50mg), the actin-binding peptide TB-500 (10mg), and the pentadecapeptide BPC-157 (10mg). The three peptides are supplied together as a single lyophilized stack so researchers can run protocols that depend on the fixed three-component ratio without separately reconstituting three vials.

Every batch of GLOW is independently verified by a third-party analytical laboratory using high-performance liquid chromatography (HPLC) and mass spectrometry. Each component peptide is tested before blending, and the combined Certificate of Analysis is published on our COAs page and linked from this product page by batch number.

What is GLOW peptide?

GLOW peptide is the Velora Research naming convention for the GHK-Cu plus Wolverine Blend stack. The name refers to the three research peptides combined in the 70mg vial. Each component has independent published research literature, and the combination is supplied for protocols that investigate the three pathways together.

GLOW peptide stack composition and per-component research overview

The three components of the GLOW peptide stack and their published research areas (in research-frame voice only, no therapeutic claims):

GHK-Cu (50mg): copper tripeptide

GHK-Cu is the copper-bound form of the tripeptide glycyl-L-histidyl-L-lysine. The compound has been studied in cell-culture and preclinical models across copper-transport chemistry, antioxidant and ROS-pathway research, fibroblast-derived collagen Type I synthesis assays, matrix-metalloproteinase expression research, and gene-expression profiling on cell-repair and oxidative-stress-response gene clusters. GHK-Cu is the largest component of the GLOW stack by mass.

TB-500 (10mg): thymosin beta-4 fragment

TB-500 is a synthetic peptide derived from the actin-binding region of thymosin beta-4 (Tβ4). It has been characterized in preclinical literature as an actin-modulating peptide with documented research activity in cell-migration assays, angiogenesis models, and cell-culture studies of fibroblast behavior.

BPC-157 (10mg): pentadecapeptide

BPC-157 (Body Protective Compound 157) is a synthetic 15-amino-acid peptide derived from a partial sequence of a body-protection compound found in human gastric juice. Published preclinical research has characterized BPC-157 across growth-factor pathway research, nitric-oxide-pathway research, and angiogenesis-research models. BPC-157 and TB-500 are also supplied together in Velora’s stand-alone Wolverine Blend product.

All mechanisms above are drawn from peer-reviewed preclinical and in-vitro research literature. Velora Research supplies the GLOW peptide blend solely for further laboratory investigation of these pathways. Nothing about the blend or its components is claimed to produce any specific outcome in humans, animals, or cosmetic applications.

Why researchers select the GLOW peptide stack

The combination of GHK-Cu plus the Wolverine Blend (BPC-157 + TB-500) in a single fixed-ratio vial is selected in research protocols that target the matrix and tissue-research pathway space in parallel. Each component engages distinct molecular targets:

  • GHK-Cu: copper-transport chemistry, collagen-pathway research, gene-expression effects on repair clusters.
  • TB-500: actin binding, cell-migration assays, angiogenesis-research models.
  • BPC-157: growth-factor pathways, nitric-oxide pathways, angiogenesis research.

Researchers running studies that benefit from the three molecular pathways in parallel often select the GLOW stack rather than reconstituting three separate vials, both for protocol consistency and for cost efficiency at the per-mg level.

Key specifications

Attribute Specification
Research name GLOW peptide blend
Alternate names GLOW peptide stack, GLOW blend
Composition 50mg GHK-Cu + 10mg TB-500 + 10mg BPC-157 (70mg combined)
Form Lyophilized blue-tinted powder (color from GHK-Cu copper coordination)
Per-component purity 99% or higher (HPLC verified independently before blending)
Combined COA Single batch COA covering all three component peptides
Storage (lyophilized) -20°C, sealed, dry, dark (light-sensitive due to GHK-Cu component)
Storage (reconstituted) 2 to 8°C protected from light, single-use aliquots recommended
Verification Independent third-party HPLC and mass spectrometry per component
COA access Batch-specific COA at verify.janoshik.com (linked from this page)

GLOW peptide blend pricing

Velora Research lists the GLOW peptide stack at a single transparent tier:

Vial size Price (USD) Best for
70mg combined $80.00 (sale price; regular $100.00) Pilot studies, multi-pathway tissue-research protocols, comparative studies that depend on the fixed three-peptide ratio without separate reconstitution of three vials

Free US shipping applies on orders over $200. The 70mg GLOW vial nearly clears the free-shipping threshold on its own; adding a vial of bacteriostatic water or any other compound brings the order over the threshold automatically. International orders are accepted in accordance with applicable research regulations.

GLOW peptide stack vs buying components separately: cost analysis

Researchers evaluating the GLOW stack often weigh it against ordering the components separately from Velora’s catalog. Approximate cost comparison:

Purchase path Approximate cost Considerations
GLOW peptide blend (70mg) $80.00 (sale) 50mg GHK-Cu + 10mg TB-500 + 10mg BPC-157 in one vial. Single reconstitution. Fixed ratio. One COA covers all three components.
Components ordered separately GHK-Cu 100mg vial ($60) + Wolverine Blend 5mg/5mg vial ($60) = ~$120 for similar combined mass Two vials, two reconstitutions, two COAs to manage. Higher per-mg cost but allows custom ratios.

The GLOW stack is cost-efficient when the protocol calls for the specific 50:10:10 ratio of GHK-Cu, TB-500, and BPC-157. Researchers needing custom ratios, or single-component protocols, may prefer to order the components separately.

Buy GLOW peptides online from Velora Research: why qualified researchers choose us

  • Per-component COA. Each peptide in GLOW (GHK-Cu, TB-500, BPC-157) is HPLC and mass-spec verified independently before blending. The combined COA shows individual component purity values, not just a single bulk-blend purity figure.
  • Component disclosure on the product page. The 50mg + 10mg + 10mg breakdown is published directly on the page. Many competitor ‘glow’ stacks list opaque proprietary blends without disclosing what is inside.
  • Light-protected packaging. GHK-Cu (the largest component by mass) is light-sensitive. Velora ships GLOW in opaque protective material to preserve copper coordination during transit.
  • US-based 2-day shipping. Free over $200; orders processed within 1 to 2 business days.
  • Compliance-first sales policy. Sales restricted to qualified laboratories, institutions, and research professionals. Research-use-only terms acknowledged at checkout.

Reconstitution and storage guidance (research use)

Velora’s GLOW peptide blend ships as a lyophilized powder with a faint blue tint characteristic of the GHK-Cu component’s copper coordination. For in vitro studies, researchers typically reconstitute with bacteriostatic water (0.9% benzyl alcohol) at a concentration matched to the assay protocol. A common pilot ratio for the 70mg combined vial is 5 mL of bacteriostatic water, yielding a 14 mg/mL stock solution of the combined blend (10 mg/mL of GHK-Cu plus 2 mg/mL each of TB-500 and BPC-157). Adjust per study design.

  • Pre-reconstitution: store sealed at -20°C in a dry, dark environment. The GHK-Cu component is light-sensitive, so keep the vial protected from ambient light.
  • Post-reconstitution: refrigerate at 2 to 8°C protected from light and use within the stability window established by the research protocol. Single-use aliquots reduce repeated light and temperature exposure, which matters more in multi-component blends than in single-peptide compounds.
  • Handling: reconstitute and aliquot under sterile lab conditions with appropriate PPE.

Velora Research supplies bacteriostatic water as a separate product. Please refer to the peer-reviewed literature and to component-specific stability data for protocol-specific reconstitution and handling parameters.

Related products

Mots-c-main

MOTS-c

$64.99

10 MG

hcg-main

HCG

$69.99

5000 IU